Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
NCT ID:
NCT01515995
Eligibility Criteria:
Inclusion Criteria:
* Patients age ≥ seven years
* Previous diagnosis of asthma or previous episode of wheezing treated with beta-agonist medication
* Able to complete bedside spirometry
* FEV1 \< 70% predicted
Exclusion Criteria:
* Known allergy to magnesium sulfate
* Known contra-indication to albuterol
* Respiratory distress occurring as a result of bedside spirometry
* History of neuromuscular disease, cardiac disease, renal disease, or underlying chronic lung disease
* Pregnancy
* Use of oral steroid medication within 72 hours of presentation
* Radiographic evidence of pneumonia at presentation
* Intubation during the current encounter prior to study enrollment
* Administration of intravenous magnesium sulfate prior to study enrollment
* Prior participation in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
18 Years
Study:
NCT01515995
Study Brief:
Protocol Section:
NCT01515995